Nucleix (NUCLEIX IT)

The company develops and provides non-invasive molecular diagnostic tests for early cancer detection and monitoring. It utilizes advanced next-generation sequencing (NGS) and PCR-based technologies to identify specific methylation changes, enabling healthcare providers to detect primary and recurring cancers.